Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11,446Revenue $M10,499Net Margin (%)-2.7Altman Z-Score0.5
Enterprise Value $M42,109EPS $-0.8Operating Margin %14.7Piotroski F-Score7
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-1.3Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %10.5Quick Ratio1.3Cash flow > EarningsY
Price/Sales1.25-y EBITDA Growth Rate %55.9Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow5.7y-y EBITDA Growth Rate %53.4ROA % (ttm)-0.8Higher Current Ratio y-yY
Dividend Yield %--PEG0.4ROE % (ttm)-5.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)-12.0Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXBill Ackman 2015-12-31 Reduce-3.69%$70.32 - $182.32
($111.15)
$ 33.36-70%Reduce -14.80%16,591,122
VRXWallace Weitz 2015-12-31 Sold Out -3.52%$70.32 - $182.32
($111.15)
$ 33.36-70%Sold Out0
VRXJohn Paulson 2015-12-31 Add2.74%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 49.22%13,265,900
VRXGlenn Greenberg 2015-12-31 Add2.72%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 12.09%6,252,331
VRXLou Simpson 2015-12-31 Add2.51%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 38.18%2,698,614
VRXLeon Cooperman 2015-12-31 Sold Out -1.75%$70.32 - $182.32
($111.15)
$ 33.36-70%Sold Out0
VRXSteve Mandel 2015-12-31 Reduce-1.23%$70.32 - $182.32
($111.15)
$ 33.36-70%Reduce -21.88%5,829,079
VRXChris Davis 2015-12-31 Add0.97%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 150.74%3,784,012
VRXRuane Cunniff 2015-12-31 Add0.84%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 4.28%35,375,610
VRXPrivate Capital 2015-12-31 Add0.5%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 13.26%336,306
VRXFirst Eagle Investment 2015-12-31 Add0.15%$70.32 - $182.32
($111.15)
$ 33.36-70%Add 55.41%1,640,132
VRXJoel Greenblatt 2015-12-31 Sold Out -0.15%$70.32 - $182.32
($111.15)
$ 33.36-70%Sold Out0
VRXKen Fisher 2015-12-31 Sold Out $70.32 - $182.32
($111.48)
$ 33.36-70%Sold Out0
VRXLeon Cooperman 2015-09-30 Buy 1.75%$158.08 - $262.52
($233.19)
$ 33.36-86%New holding484,915
VRXSteve Mandel 2015-09-30 Add1.62%$158.08 - $262.52
($233.19)
$ 33.36-86%Add 40.52%7,461,780
VRXLou Simpson 2015-09-30 Add1.35%$158.08 - $262.52
($233.19)
$ 33.36-86%Add 13.00%1,952,983
VRXGlenn Greenberg 2015-09-30 Reduce-0.79%$158.08 - $262.52
($233.19)
$ 33.36-86%Reduce -2.16%5,577,892
VRXWallace Weitz 2015-09-30 Reduce-0.54%$158.08 - $262.52
($233.19)
$ 33.36-86%Reduce -12.08%630,155
VRXChris Davis 2015-09-30 Reduce-0.2%$158.08 - $262.52
($233.19)
$ 33.36-86%Reduce -14.36%1,509,122
VRXPrivate Capital 2015-09-30 Reduce-0.14%$158.08 - $262.52
($233.19)
$ 33.36-86%Reduce -1.91%296,931
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.48-55.08view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-80.59view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-83.98view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-84.33view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-86.14view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.51-84.84view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.24-83.99view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-86.48view
Mirovsky PavelEVP, Pres. & GM Valeant EMENA 2015-06-02Sell38,000$238.01-85.19view
Whitaker Anne ClemDirector 2015-05-26Buy7,500$234.67-84.98view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
Ackman to Testify About Valeant Before Senate Apr 26 2016 
Weitz Funds' Research Fund Commentary 1st Quarter Apr 25 2016 
Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 
Wallace Weitz Comments on Valeant Pharmaceuticals Apr 22 2016 
Bernard Horn's 1st Quarter 2016 Polaris Global Value Fund Apr 22 2016 
Weitz Value Funds' 1st Quarter 2016 Commentry Apr 22 2016 
With Ackman Down It May Be Right Time to Back Him Apr 21 2016 
Mawer's Investment Newsletter 1st Quarter Apr 15 2016 
2 Major Mergers Come to End After Tough Stance From Regulators Apr 07 2016 
Notes From the Pershing Square 1st Quarter Call Apr 07 2016 

More From Other Websites
[$$] Valeant Files Overdue Annual Report, Easing Risk of Default Apr 29 2016
Early movers: AMZN, VRX, TIVO, TYC, DAL, VFC, MCO, NWL, BUD & more Apr 29 2016
Valeant Beats Self-Imposed Deadline to File Annual Report Apr 29 2016
Valeant Beats Self-Imposed Deadline to File Annual Report Apr 29 2016
Valeant files annual report, says in compliance with covenants Apr 29 2016
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial... Apr 29 2016
Valeant Pharmaceuticals Files Annual Report On Form 10-K For Year Ended December 31, 2015 Apr 29 2016
The disastrous Valeant document everyone's been waiting for is finally here Apr 29 2016
Valeant Files Annual Report, Discloses State Investigations Apr 29 2016
7:29 am Valeant Pharma confirms it filed its Annual Report On Form 10-K, says no additional items... Apr 29 2016
Valeant Pharmaceuticals Files Annual Report On Form 10-K For Year Ended December 31, 2015 Apr 29 2016
Valeant Pharmaceuticals Files Annual Report On Form 10-K For Year Ended December 31, 2015 Apr 29 2016
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 10-K, Annual Report Apr 29 2016
[$$] Valeant: Swapping Scandal for Growing Pains Apr 28 2016
Cramer: Worst May Be Over for Embattled Pharma Apr 28 2016
Will Valeant Change Its Drug-Pricing Practices? Apr 28 2016
Sen. Collins: I Hope Valeant Lowers Its Prices Apr 28 2016
Sen. Collins: I Hope Valeant Lowers Its Prices Apr 28 2016
Ackman’s testimony suggests he’s in charge at Valeant Apr 28 2016
Now we have a clue just how close Valeant came to the brink Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)